Miltenyi Biomedicine

German multinational Miltenyi Biotec’s senior leadership sees significant opportunities for India in the cell and gene therapy space if it can get things right in terms of shaping the regulatory frame

Companies looking to bring the first CAR-T treatment for autoimmune diseases to market will present their latest data at the European Alliance of Associations for Rheumatology (EULAR) meeting this wee

In what the authors call the first study of its kind, a team of researchers at the non-profit Caring Cross have successfully used point-of-care manufacturing technology to create T-cells to treat pa

Provention Bio has become the first company to get an investigational treatment for diabetes accepted onto the European Medicines Agency’s PRIME (priority medicines) scheme, which aims to get drugs f